ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $892,000 | – | 26,882 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 750,000 | $25,875,000 | 0.22% |
| AWM Investment Company, Inc. | 19,981 | $689,000 | 0.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 5,653 | $183,000 | 0.08% |
| OLD MISSION CAPITAL LLC | 15,890 | $548,000 | 0.05% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,433,091 | $49,442,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 10,000 | $345,000 | 0.01% |
| STATE OF WISCONSIN INVESTMENT BOARD | 44,092 | $1,521,000 | 0.01% |
| Rockefeller Capital Management L.P. | 8,876 | $306,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 236 | $10,000 | 0.00% |
| Filbrandt Wealth Management, LLC | 25 | $1,000 | 0.00% |